Table 4 Cox model of factors associated with overall survival.

From: COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors

 

HR (95% CI)

P-value

COPD

0.63 (0.47–0.85)

0.007

Age

1.04 (0.98–1.09)

0.10

Smoking (pack-year)

0.88 (0.65–1.27)

0.23

Performans status

1.15 (0.75–1.32)

0.22

Number of lines

1.00 (0.95–1.17)

0.26

Histology (adenocarcinoma as reference)

0.98 (0.95–1.07)

0.13

  1. COPD chronic obstructive pulmonary disease, HR hazard ratio, CI confidence interval.
Back to article page